ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search

OR

CurrentAll Trials

IP2-ATLANTA

Trial Details

An unblinded randomised controlled trial to test a new way to treat advanced disease, targeting the initial tumour inside the prostate to slow the growth of other tumours around the body.

Design and Objective

Comparing standard treatment (Control Arm) to standard treatment with minimally invasive ablative therapy- heat/freeze (Arm 1) or radical therapy- radiotherapy/prostatectomy (Arm 2). Some men in arm 1 and 2 will also get treatment to metastases. Aim is to find differences between 3 arms in terms of treating cancer, side effects and quality of life.

Key inclusion criteria

Men who are willing to undergo local therapy and mets-directed therapy for metastatic prostate cancer in addition to standard of care systemic treatment.

Study Disclaimer Statement